Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease-Reference-Cited by-同舟云学术

Staging of tau distribution by positron emission tomography may be useful in clinical staging of Alzheimer disease

Published:2020-01-09 Issue:2 Volume:8 Page:61-67
ISSN:2049-4173
Container-title:Neurology and Clinical Neuroscience
language:en
Short-container-title:Neurology & Clinical Neurosc

Author:

Aohara Kenta¹,Minatani Shinobu¹,Kimura Hiroko¹,Takeuchi Jun¹,Takeda Akitoshi¹,Kawabe Joji²,Wada Yasuhiro³,Mawatari Aya³,Watanabe Yasuyoshi³,Shimada Hitoshi⁴,Higuchi Makoto⁴,Suhara Tetsuya⁴,Itoh Yoshiaki¹^ORCID

Affiliation:

1. Department of Neurology Osaka City University Graduate School of Medicine Osaka Japan

2. Department of Nuclear Medicine Osaka City University Graduate School of Medicine Osaka Japan

3. RIKEN Center for Biosystems Dynamics Research Kobe Japan

4. Department of Functional Brain Imaging Research (DOFI), Clinical Research Cluster National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST) Chiba Japan

Funder

National Institute of Radiological Sciences

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1111/ncn3.12366

Reference32 articles.

1. The molecular pathology of Alzheimer's disease

2. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology

3. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease